National Academies Press: OpenBook
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

The Role of
Purchasers and Payers
in the
Clinical Research Enterprise

WORKSHOP SUMMARY

Sean Tunis, Allan Korn, and Alex Ommaya, Editors

Based on a Workshop of the Clinical Research Roundtable

Board on Health Sciences Policy

INSTITUTE OF MEDICINE

NATIONAL ACADEMY PRESS
Washington, D.C.

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

NATIONAL ACADEMY PRESS
2101 Constitution Avenue, N.W. Washington, DC 20418

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

Support for this project was provided by Agency for Healthcare Research and Quality, American Medical Association, Association of American Medical Colleges, BlueCross/BlueShield Association, Burroughs Wellcome Fund, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services (formerly HCFA), Department of Veterans Affairs, Doris Duke Charitable Foundation, Food and Drug Administration, Johnson & Johnson, Merck and Company, National Institutes of Health, Pfizer, Inc., and the Robert Wood Johnson Foundation. The views presented in this report are those of the authors and are not necessarily those of the funding agencies.

International Standard Book Number 0-309-08349-4

Library of Congress Control Number 2002106553

Additional copies of this report are available for sale from the
National Academy Press,
2101 Constitution Avenue, N.W., Box 285, Washington, D.C.20055. Call (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area), or visit the NAP’s home page at www.nap.edu. The full text of this report is available at www.nap.edu.

For more information about the Institute of Medicine, visit the IOM home page at: www.iom.edu.

Copyright 2002 by the National Academy of Sciences. All rights reserved.

Printed in the United States of America.

The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

“Knowing is not enough; we must apply.

Willing is not enough; we must do.”

—Goethe

INSTITUTE OF MEDICINE

Shaping the Future for Health

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

THE NATIONAL ACADEMIES

National Academy of Sciences

National Academy of Engineering

Institute of Medicine

National Research Council

The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Bruce M. Alberts is president of the National Academy of Sciences.

The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Wm. A. Wulf is president of the National Academy of Engineering.

The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine.

The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Bruce M. Alberts and Dr. Wm. A. Wulf are chairman and vice chairman, respectively, of the National Research Council.

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

CLINICAL RESEARCH ROUNDTABLE

WILLIAM GERBERDING, (Co-chair), President Emeritus,

University of Washington, Seattle, Washington

ENRIQUETA BOND, (Co-chair) President,

Burroughs Wellcome Fund, Research Triangle Park, North Carolina

TOM BEAUCHAMP, Professor of Philosophy and Senior Research Scholar,

Kennedy Institute of Ethics, Georgetown University, Washington, D.C.

VERONICA CATANESE, Associate Dean,

New York University School of Medicine, Director of Development, American Federation for Medical Research Foundation, New York, New York

FRANCIS CHESLEY, Director,

Office of Research, Review, Education and Policy, Agency for Healthcare Research and Quality, Rockville, Maryland

WILLIAM F. CROWLEY, JR., Professor of Medicine,

Harvard University,

Director of Clinical Research,

Massachusetts General Hospital, Boston, Massachusetts

ADRIAN DOBS, Professor of Medicine, Director,

Clinical Research Unit, Johns Hopkins University School of Medicine, Baltimore, Maryland

JOHN FEUSSNER, Chief Research and Development Officer,

Department of Veterans Affairs, Washington, D.C.

MYRON GENEL, Associate Dean,

Office of Government and Community Affairs, Yale University School of Medicine, New Haven, Connecticut

KENNETH GETZ, President/Publisher,

CenterWatch, Boston, Massachusetts

JACK GREBB, Senior Vice President,

Johnson & Johnson, Global CNS/ Analgesia Clinical Research and Development, Janssen Research Foundation, Titusville, New Jersey

LAWRENCE GREEN, Director,

Office of Extramural Prevention Research, Centers for Disease Control and Prevention, Atlanta, Georgia

STEPHEN KATZ, Director,

National Institute of Arthritis and Musculoskeletal and Skin Diseases, Chief, Dermatology Branch, National Cancer Institute, Bethesda, Maryland

ALLAN M. KORN, Senior Vice President, Chief Medical Officer,

Blue Cross Blue Shield Association, Chicago, Illinois

DAVID KORN, Senior Vice President for Biomedical and Health Sciences Research,

Association of American Medical Colleges, Washington, D.C.

ELAINE L. LARSON, Professor of Pharmaceutical and Therapeutic Research,

Columbia University School of Nursing, New York, New York

E. ALBERT REECE, Vice Chancellor and Dean,

University of Arkansas College of Medicine, Little Rock, Arkansas

DAVID L. RIMOIN, Chairman of Pediatrics and Director,

Medical Genetics-Birth Defects Center Cedars-Sinai Medical Center, Los Angeles, California

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

PATRICIA SALBER, Medical Director for Managed Care Health Care Initiative,

General Motors Co., The Permanente Company, Larkspur, California

LEWIS SANDY, Executive Vice President,

Robert Woods Johnson Foundation, Princeton, New Jersey

DAVID SCHEINBERG, Doris Duke Clinical Science Professor Chief,

Leukemia Service, Memorial Sloan-Kettering Cancer, New York, New York

BERNARD SCHWETZ, Acting Deputy Commissioner and Senior Advisor for Science,

Food and Drug Administration, Rockville, Maryland

LOUIS SHERWOOD, Senior Vice President for Medical and Scientific Affairs,

Merck and Co., West Point, Pennsylvania

LANA SKIRBOLL, Director,

Office of Science Policy, National Institutes of Health, Rockville, Maryland

HAROLD SLAVKIN, Dean, G. Donald and Marian James Montgomery Professor of Dentistry,

School of Dentistry, University of Southern California, Los Angeles, California

SEAN TUNIS, Director,

Coverage and Analysis Group, Office of Clinical Standards and Quality Centers for Medicare and Medicaid Services

MYRL WEINBERG, President,

National Health Council, Washington, D.C.

MICHAEL J. WELCH, Co-Director,

Division of Radiological Sciences, The Edward Mallincrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri

Liaisons to the Clinical Research Roundtable

STEVEN PAUL, Group Vice President,

Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center

HUGH TILSON, Senior Advisor to the Dean,

School of Public Health, University of North Carolina

MARY WOOLLEY, President,

Research!America

Study Staff

ALEX OMMAYA, Study Director

ANDREA KALFOGLOU, Program Officer

VANESSA WALKER, Research Assistant

PERRY LUKSIN, Senior Project Assistant

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

Division Staff

ANDREW POPE, Division Director

ALDEN CHANG, Administrative Assistant

CARLOS GABRIEL, Financial Associate

LAURIE YELLE, Consultant

Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

REVIEWERS

This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the NRC’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. We wish to thank the following individuals for their review of this report:

Edward Campion, M.D., New England Journal of Medicine

Carolyn Clancy, M.D., Agency for Healthcare Research and Quality (AHRQ)

Michael R. McGarvey, M.D., Chief Medical Officer BCBSNJ, Retired

Although the reviewers listed above have provided many constructive comments and suggestions, they were not asked to endorse the conclusions nor did they see the final draft of the report before its release. The review of this report was overseen by Mel Worth, Scholar-in-Residence, Institute of Medicine, who was responsible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this report rests entirely with the authoring committee and the institution.

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

Foreword

Enriqueta Bond, Ph.D.

Liaison, Institute of Medicine

President, Burroughs Wellcome Fund

Research Triangle Park, North Carolina

The Clinical Research Roundtable was convened by the Institute of Medicine in early 2000. Since then the roundtable has discussed many issues relevant to clinical research and has sponsored several symposia, the proceedings for which are available on its website www.iom.edu/crr. The roundtable brings together individuals from the academic health community, federal agencies sponsoring and regulating clinical research, private-sector sponsors of clinical research, foundations, public- and private-sector insurance programs, health plans and insurance companies, corporate purchasers of health care, and representatives of patient interests. Their mission is to discuss the challenges facing the Clinical Research Enterprise and the approaches that might be adapted to create a more supportive and efficient environment for the conduct of a broad agenda of high-quality clinical research to benefit the American public.

The roundtable provides a forum and sponsors workshops for discussion of approaches to resolving both acute and long-term issues affecting clinical research. It strives to enhance mutual understanding of clinical research between the scientific community and the general public, while improving the public’s understanding of and participation in clinical studies.

Some issues germane to the development and continued vitality of clinical research include workforce career development in clinical research across the health professions; the linkage between discoveries in basic science and their application to improved patient care; the essential coordination of clinical research within and between research entities and disciplines; the ability of academic health centers to conduct clinical research and training; the broad participation of health professionals in clinical research across all practice settings and emerging health care systems; the timely incorporation into clinical practice of

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

new research findings and findings on health outcomes; and the availability of financial and other data to monitor and assess the different components of patient- and population-based health research.

The Clinical Research Roundtable was created to provide a place where a very complicated set of actors, who are all very important to the Clinical Research Enterprise, could begin to talk to one another and gain a better understanding of each others’ perspectives. The workshop has well launched us on that course. Many significant follow-up activities were exposed during the workshop that will allow us to continue to better identify and describe how to advance the Clinical Research Enterprise in ways that will greatly improve patient health. The ideas presented in this summary are exciting and display a great openness of the payer-purchaser community and a variety of efforts under way to the challenges that arose during the workshop.

This workshop focused specifically on what purchasers (employers) and payers (insurance companies) want from the Clinical Research Enterprise, what their role is with respect to the enterprise, and what they can contribute to it. Since its inception the Clinical Research Roundtable has been working to define the dimension and size of the Clinical Research Enterprise. We have identified how large and how fragmented the enterprise is, and we have determined that the advancement of the nation’s health depends critically on all the pieces working together in a much better way than they do now and on our gaining better understanding of each other’s roles.

The workshop explored the following questions with the purchasers and payers: What do purchasers and payers need from the Clinical Research Enterprise? How have current efforts in clinical research met your needs? What steps are necessary to improve the Clinical Research Enterprise? What are your top priorities for clinical research? Who should fund research studies? What are purchasers and payers willing to contribute to the Clinical Research Enterprise? Can you point to effective partnerships that have produced worthwhile results from the purchaser and payer perspectives? What are the most effective methods for addressing questions of interest for purchasers and payers?

The agenda of the workshop, as reflected in the summaries of the workshop presentations contained in this report, was organized to elicit the responses to these questions first from the perspective of purchasers (employers), then from the perspective of payers (health plans and insurance companies), and finally from the perspective of stakeholders (voluntary health associations and researchers). In the final session of the workshop, opportunities and challenges in the Clinical Research Enterprise were discussed from the perspective of all participants in the enterprise, including consumers. Although speakers expressed many diverse points of view during the workshop, all recognized the opportunity for health care purchasers, payers, researchers, and other stakeholders to work collaboratively, as part of the Clinical Research Enterprise, to meet the many challenges in this country’s health care.

Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×

2

 

THE ROLE OF PAYERS IN THE CLINICAL RESEARCH ENTERPRISE

 

29

   

Introduction,

 

29

   

What Payers Need from the Clinical Research Enterprise,

 

30

   

What Payers Are Willing to Contribute to the Clinical Research Enterprise,

 

37

   

Research Priorities and Priority Setting for Payers,

 

40

   

Translational Blocks,

 

43

   

Consumer Demand,

 

47

   

Patient Participation in Clinical Research,

 

48

   

Summary,

 

48

3

 

THE ROLE OF OTHER STAKEHOLDERS IN THE CLINICAL RESEARCH ENTERPRISE

 

51

   

Introduction,

 

51

   

The Role of Voluntary Health Associations in the Clinical Research Enterprise,

 

52

   

Priority Setting in Basic and Clinical Research,

 

56

   

Priority Setting in Health Services Research,

 

58

   

Health Services Research in Voluntary Health Associations,

 

61

   

The Role of the Device Industry in the Clinical Research Enterprise,

 

63

   

The Role of the Agency for Healthcare Research and Quality in the Clinical Research Enterprise,

 

65

   

Translational Blocks and Practice Guidelines,

 

66

   

Summary,

 

68

4

 

OPPORTUNITIES AND CHALLENGES IN THE CLINICAL RESEARCH ENTERPRISE

 

70

   

Introduction,

 

70

   

Outcomes Research and Disease Management,

 

71

   

Integrated Patient-Centered Care,

 

75

   

Research Priorities in Pharmaceutical Companies,

 

75

   

Summary,

 

80

 

 

SUGGESTED READINGS

 

82

APPENDIX I:

 

Speaker Biographies

 

83

APPENDIX II

 

Speaker’s Company Profiles

 

90

APPENDIX III:

 

Purchaser Payer Background Information

 

94

Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
This page in the original is blank.
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R1
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R2
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R3
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R4
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R5
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R6
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R7
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R8
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R9
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R10
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R11
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R12
Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R13
Suggested Citation:"Front Matter." Institute of Medicine. 2002. The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10400.
×
Page R14
Next: Workshop Summary »
The Role of Purchasers and Payers in the Clinical Research Enterprise: Workshop Summary Get This Book
×
Buy Paperback | $30.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

In a workshop organized by the Clinical Research roundtable, representatives from purchaser organizations (employers), payer organizations (health plans and insurance companies), and other stakeholder organizations (voluntary health associations, clinical researchers, research organizations, and the technology community) came together to explore:

  • What do purchasers and payers need from the Clinical Research Enterprise?
  • How have current efforts in clinical research met their needs?
  • What are purchasers, payers, and other stakeholders willing to contribute to the enterprise?

This book documents these discussions and summarizes what employers and insurers need from and are willing to contribute to clinical research from both a business and a national health care perspective.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!